Haemodilution in acute stroke: Results of the Italian haemodilution trial

L. Candelise, R. Colombo, M. Rango, G. Pinardi, C. Fieschi, C. Argentino, F. Giubilei, M. Rasura, S. Cappellari, A. Casazza, L. Grilli, C. P. Warlow, R. Peto, A. Morabito

Research output: Contribution to journalArticle

Abstract

In a multicentre clinical trial 1267 patients with hemispheric stroke of duration 12 h or less and haematocrit of 35% or more were prospectively randomised to either haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution) or control treatment groups. In the haemodiluted group mean haematocrit declined from 43% to 37% at 48 h and this fall was maintained for seven days. A plain computed tomographic scan was obtained in all but 37 patients. 87% of the strokes were infarcts and 13% were haemorrhages. After six months the numbers of dead or severely disabled patients were equally distributed in the two treatment groups, and this was true also within the ischaemic and haemorrhagic subgroups. Furthermore, haemodilution did not improve outcome either in the group with very recent ischaemic stroke (<6 h) or in the subgroup with highest haematocrit (> 45%). Thus, moderate haemodilution does not improve the outcome in acute stroke patients.

Original languageEnglish
Pages (from-to)318-321
Number of pages4
JournalLancet
Volume1
Issue number8581
Publication statusPublished - 1988

Fingerprint

Hemodilution
Stroke
Hematocrit
Phlebotomy
Dextrans
Sodium Chloride
Multicenter Studies
Clinical Trials
Hemorrhage
Control Groups
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Candelise, L., Colombo, R., Rango, M., Pinardi, G., Fieschi, C., Argentino, C., ... Morabito, A. (1988). Haemodilution in acute stroke: Results of the Italian haemodilution trial. Lancet, 1(8581), 318-321.

Haemodilution in acute stroke : Results of the Italian haemodilution trial. / Candelise, L.; Colombo, R.; Rango, M.; Pinardi, G.; Fieschi, C.; Argentino, C.; Giubilei, F.; Rasura, M.; Cappellari, S.; Casazza, A.; Grilli, L.; Warlow, C. P.; Peto, R.; Morabito, A.

In: Lancet, Vol. 1, No. 8581, 1988, p. 318-321.

Research output: Contribution to journalArticle

Candelise, L, Colombo, R, Rango, M, Pinardi, G, Fieschi, C, Argentino, C, Giubilei, F, Rasura, M, Cappellari, S, Casazza, A, Grilli, L, Warlow, CP, Peto, R & Morabito, A 1988, 'Haemodilution in acute stroke: Results of the Italian haemodilution trial', Lancet, vol. 1, no. 8581, pp. 318-321.
Candelise L, Colombo R, Rango M, Pinardi G, Fieschi C, Argentino C et al. Haemodilution in acute stroke: Results of the Italian haemodilution trial. Lancet. 1988;1(8581):318-321.
Candelise, L. ; Colombo, R. ; Rango, M. ; Pinardi, G. ; Fieschi, C. ; Argentino, C. ; Giubilei, F. ; Rasura, M. ; Cappellari, S. ; Casazza, A. ; Grilli, L. ; Warlow, C. P. ; Peto, R. ; Morabito, A. / Haemodilution in acute stroke : Results of the Italian haemodilution trial. In: Lancet. 1988 ; Vol. 1, No. 8581. pp. 318-321.
@article{e638241045464dcbac606b58652d3bd7,
title = "Haemodilution in acute stroke: Results of the Italian haemodilution trial",
abstract = "In a multicentre clinical trial 1267 patients with hemispheric stroke of duration 12 h or less and haematocrit of 35{\%} or more were prospectively randomised to either haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution) or control treatment groups. In the haemodiluted group mean haematocrit declined from 43{\%} to 37{\%} at 48 h and this fall was maintained for seven days. A plain computed tomographic scan was obtained in all but 37 patients. 87{\%} of the strokes were infarcts and 13{\%} were haemorrhages. After six months the numbers of dead or severely disabled patients were equally distributed in the two treatment groups, and this was true also within the ischaemic and haemorrhagic subgroups. Furthermore, haemodilution did not improve outcome either in the group with very recent ischaemic stroke (<6 h) or in the subgroup with highest haematocrit (> 45{\%}). Thus, moderate haemodilution does not improve the outcome in acute stroke patients.",
author = "L. Candelise and R. Colombo and M. Rango and G. Pinardi and C. Fieschi and C. Argentino and F. Giubilei and M. Rasura and S. Cappellari and A. Casazza and L. Grilli and Warlow, {C. P.} and R. Peto and A. Morabito",
year = "1988",
language = "English",
volume = "1",
pages = "318--321",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "8581",

}

TY - JOUR

T1 - Haemodilution in acute stroke

T2 - Results of the Italian haemodilution trial

AU - Candelise, L.

AU - Colombo, R.

AU - Rango, M.

AU - Pinardi, G.

AU - Fieschi, C.

AU - Argentino, C.

AU - Giubilei, F.

AU - Rasura, M.

AU - Cappellari, S.

AU - Casazza, A.

AU - Grilli, L.

AU - Warlow, C. P.

AU - Peto, R.

AU - Morabito, A.

PY - 1988

Y1 - 1988

N2 - In a multicentre clinical trial 1267 patients with hemispheric stroke of duration 12 h or less and haematocrit of 35% or more were prospectively randomised to either haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution) or control treatment groups. In the haemodiluted group mean haematocrit declined from 43% to 37% at 48 h and this fall was maintained for seven days. A plain computed tomographic scan was obtained in all but 37 patients. 87% of the strokes were infarcts and 13% were haemorrhages. After six months the numbers of dead or severely disabled patients were equally distributed in the two treatment groups, and this was true also within the ischaemic and haemorrhagic subgroups. Furthermore, haemodilution did not improve outcome either in the group with very recent ischaemic stroke (<6 h) or in the subgroup with highest haematocrit (> 45%). Thus, moderate haemodilution does not improve the outcome in acute stroke patients.

AB - In a multicentre clinical trial 1267 patients with hemispheric stroke of duration 12 h or less and haematocrit of 35% or more were prospectively randomised to either haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution) or control treatment groups. In the haemodiluted group mean haematocrit declined from 43% to 37% at 48 h and this fall was maintained for seven days. A plain computed tomographic scan was obtained in all but 37 patients. 87% of the strokes were infarcts and 13% were haemorrhages. After six months the numbers of dead or severely disabled patients were equally distributed in the two treatment groups, and this was true also within the ischaemic and haemorrhagic subgroups. Furthermore, haemodilution did not improve outcome either in the group with very recent ischaemic stroke (<6 h) or in the subgroup with highest haematocrit (> 45%). Thus, moderate haemodilution does not improve the outcome in acute stroke patients.

UR - http://www.scopus.com/inward/record.url?scp=0023835884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023835884&partnerID=8YFLogxK

M3 - Article

C2 - 2448561

VL - 1

SP - 318

EP - 321

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8581

ER -